These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28828971)

  • 21. New therapies for anaplastic thyroid cancer.
    Agrawal VR; Hreno J; Patil T; Bowles DW
    Drugs Today (Barc); 2018 Nov; 54(11):695-704. PubMed ID: 30539168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous metastasis from anaplastic thyroid carcinoma exhibiting exclusively a spindle cell morphology. A case report and review of literature.
    Danialan R; Tetzlaff MT; Torres-Cabala CA; Mays SR; Prieto VG; Bell D; Curry JL
    J Cutan Pathol; 2016 Mar; 43(3):252-7. PubMed ID: 26347145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaplastic thyroid cancer: outcome and the mutation/expression profiles of potential targets.
    Wu H; Sun Y; Ye H; Yang S; Lee SL; de las Morenas A
    Pathol Oncol Res; 2015 Jul; 21(3):695-701. PubMed ID: 25588542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
    Haghpanah V; Fallah P; Naderi M; Tavakoli R; Soleimani M; Larijani B
    Life Sci; 2016 Feb; 146():34-9. PubMed ID: 26772823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathobiology of MicroRNAs and Their Emerging Role in Thyroid Fine-Needle Aspiration.
    Ludvíková M; Kalfeřt D; Kholová I
    Acta Cytol; 2015; 59(6):435-44. PubMed ID: 26745212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients.
    Fourati A; El Amine O; Ben Ayoub W; Cherni I; Goucha A; El May MV; Gamoudi A; El May A
    Bull Cancer; 2017 May; 104(5):433-441. PubMed ID: 28185633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
    Raue F; Frank-Raue K
    Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.
    Haghpanah V; Fallah P; Tavakoli R; Naderi M; Samimi H; Soleimani M; Larijani B
    Tumour Biol; 2016 Jan; 37(1):1299-308. PubMed ID: 26289851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of a 3-MicroRNA signature in cytological samples of small cell lung cancer.
    Mancuso G; Bovio E; Rena O; Rrapaj E; Mercalli F; Veggiani C; Paganotti A; Andorno S; Boldorini R
    Cancer Cytopathol; 2016 Sep; 124(9):621-9. PubMed ID: 27153322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive anaplastic thyroid carcinoma: report of a case and literature review.
    Dibelius G; Mehra S; Clain JB; Urken ML; Wenig BM
    Thyroid; 2014 Aug; 24(8):1319-24. PubMed ID: 24865498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel therapeutic targets in anaplastic thyroid carcinoma using functional genomic mRNA-profiling: Paving the way for new avenues?
    Jonker PK; van Dam GM; Oosting SF; Kruijff S; Fehrmann RS
    Surgery; 2017 Jan; 161(1):202-211. PubMed ID: 27865593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fine needle aspiration cytology of 637 thyroid nodules].
    Togon H
    Nihon Geka Gakkai Zasshi; 1983 Jul; 84(7):612-22. PubMed ID: 6676632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer.
    Xing M; Tufano RP; Tufaro AP; Basaria S; Ewertz M; Rosenbaum E; Byrne PJ; Wang J; Sidransky D; Ladenson PW
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2867-72. PubMed ID: 15181070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases.
    Bonhomme B; Godbert Y; Perot G; Al Ghuzlan A; Bardet S; Belleannée G; Crinière L; Do Cao C; Fouilloux G; Guyetant S; Kelly A; Leboulleux S; Buffet C; Leteurtre E; Michels JJ; Tissier F; Toubert ME; Wassef M; Pinard C; Hostein I; Soubeyran I
    Thyroid; 2017 May; 27(5):682-692. PubMed ID: 28351340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered expression of mir-222 and mir-25 influences diverse gene expression changes in transformed normal and anaplastic thyroid cells, and impacts on MEK and TRAIL protein expression.
    Aherne ST; Smyth P; Freeley M; Smith L; Spillane C; O'Leary J; Sheils O
    Int J Mol Med; 2016 Aug; 38(2):433-45. PubMed ID: 27353001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FOXD3 regulates anaplastic thyroid cancer progression.
    Yin H; Meng T; Zhou L; Zhao F; Li X; Li Y; Hu M; Chen H; Song D
    Oncotarget; 2017 May; 8(20):33644-33651. PubMed ID: 28430585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
    Mancikova V; Buj R; Castelblanco E; Inglada-Pérez L; Diez A; de Cubas AA; Curras-Freixes M; Maravall FX; Mauricio D; Matias-Guiu X; Puig-Domingo M; Capel I; Bella MR; Lerma E; Castella E; Reverter JL; Peinado MÁ; Jorda M; Robledo M
    Int J Cancer; 2014 Aug; 135(3):598-610. PubMed ID: 24382797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting lipid metabolism for the treatment of anaplastic thyroid carcinoma.
    von Roemeling CA; Copland JA
    Expert Opin Ther Targets; 2016; 20(2):159-66. PubMed ID: 26414044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.
    Penna GC; Vaisman F; Vaisman M; Sobrinho-Simões M; Soares P
    Cytogenet Genome Res; 2016; 150(3-4):194-207. PubMed ID: 28231576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.